(Q44255405)

1 December 2017

title

The core structure of TMC-95A is a promising lead for reversible proteasome inhibition (English)

1 reference

1 December 2017

4

Robert Huber

1 reference

1 December 2017

Markus Kaiser

1

1 reference

1 December 2017

Michael Groll

series ordinal

2

1 reference

1 December 2017

Christian Renner

series ordinal

3

1 reference

1 December 2017

Luis Moroder

series ordinal

5

1 reference

1 December 2017

publication date

1 March 2002

1 reference

1 December 2017

1 reference

1 December 2017

volume

41

1 reference

1 December 2017

issue

5

1 reference

1 December 2017

page(s)

780-783

1 reference

TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities

1 December 2017

cites work

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.53.105

Chloropeptins I and II, novel inhibitors against gp120-CD4 binding from Streptomyces sp.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.47.1173

New antiviral antibiotics, kistamicins A and B. I. Taxonomy, production, isolation, physico-chemical properties and biological activities.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.46.1804

Complestatin, a potent anti-complement substance produced by Streptomyces lavendulae. I. Fermentation, isolation and biological characterization

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.42.236

Identifiers

DOI

10.1002/1521-3773(20020301)41:5<780::AID-ANIE780>3.0.CO;2-V

1 reference

1 December 2017

1 reference